Literature DB >> 3498448

Plasma von Willebrand factor in connective tissue disease.

J L Gordon, B E Pottinger, P Woo, J Rosenbaum, C M Black.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498448      PMCID: PMC1002172          DOI: 10.1136/ard.46.6.491

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium.

Authors:  K S Sakariassen; P A Bolhuis; J J Sixma
Journal:  Nature       Date:  1979-06-14       Impact factor: 49.962

2.  Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage.

Authors:  E Angles-Cano; Y Sultan; J P Clauvel
Journal:  J Lab Clin Med       Date:  1979-08

3.  Thrombin-induced release of von Willebrand factor from endothelial cells is mediated by phospholipid methylation. Prostacyclin synthesis is independent of phospholipid methylation.

Authors:  P G de Groot; M D Gonsalves; C Loesberg; M F van Buul-Wortelboer; W G van Aken; J A van Mourik
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

4.  Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.

Authors:  H I Glueck; K S Kant; M A Weiss; V E Pollak; M A Miller; M Coots
Journal:  Arch Intern Med       Date:  1985-08

5.  The effect of an acute phase reaction and BCG innoculation on factor VIII in the guinea-pig.

Authors:  D Kelly; E G Tuddenham; J A Summerfield
Journal:  Thromb Res       Date:  1985-11-15       Impact factor: 3.944

  5 in total
  7 in total

Review 1.  Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: do we have enough evidence?

Authors:  I Gil-Bazo; J-A Díaz-González; J Rodríguez; J Cortés; E Calvo; J-A Páramo; J García-Foncillas
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

2.  Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies.

Authors:  C O Savage; B E Pottinger; G Gaskin; C M Lockwood; C D Pusey; J D Pearson
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 3.  The endothelium: its role in scleroderma.

Authors:  J D Pearson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

4.  Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma.

Authors:  Wei-Shu Wang; Jen-Kou Lin; Tzu-Chen Lin; Tzeon-Jye Chiou; Jin-Hwang Liu; Chueh-Chuan Yen; Po-Min Chen
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

5.  ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women.

Authors:  S Zouine; F Marnissi; N Otmani; M Bennani Othmani; M El Wafi; K Kojok; Y Zaid; N Tahiri Jouti; N Habti
Journal:  Med Oncol       Date:  2016-05-30       Impact factor: 3.064

Review 6.  Microvascular damage in systemic sclerosis: detection and monitoring with biomarkers.

Authors:  Laura K Hummers
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

7.  von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis.

Authors:  E Nordborg; R Andersson; L Tengborn; S Edén; B A Bengtsson
Journal:  Ann Rheum Dis       Date:  1991-05       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.